DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Treosulfan is an investigational drug.
There have been 37 clinical trials for Treosulfan. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2008.
The most common disease conditions in clinical trials are Leukemia, Myelodysplastic Syndromes, and Preleukemia. The leading clinical trial sponsors are medac GmbH, National Cancer Institute (NCI), and Fred Hutchinson Cancer Research Center.
Recent Clinical Trials for Treosulfan
|Low Dose Treosulfan Based Conditioning Regimen in HSCT for Nijmegen Breakage Syndrome||Federal Research Institute of Pediatric Hematology, Oncology and Immunology||Phase 2|
|Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies||National Cancer Institute (NCI)||Phase 2|
|Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies||Fred Hutchinson Cancer Research Center||Phase 2|